|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.44 USD | -7.73% |
|
+16.08% | +42.92% |
| 04:35pm | Wedbush Adjusts Price Target on NovoCure to $20 From $18, Maintains Neutral Rating | MT |
| 07-23 | NovoCure Limited, Q2 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 2.33B 2.04B 1.9B 1.74B 3.28B 224B 3.33B 22.58B 8.82B 110B 8.74B 8.55B 381B | P/E 2026 * |
-16x | P/E 2027 * | -22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.13B 1.87B 1.74B 1.6B 3B 205B 3.05B 20.69B 8.08B 101B 8.01B 7.83B 349B | EV / Sales 2026 * |
2.94x | EV / Sales 2027 * | 2.48x |
| Free-Float |
89.99% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NovoCure Limited
| 1 day | -7.73% | ||
| 1 week | +16.08% | ||
| Current month | +21.98% | ||
| 1 month | +25.54% | ||
| 3 months | +48.20% | ||
| 6 months | +39.37% | ||
| Current year | +42.92% |
| 1 week | 15.2 |  | 21.45 |
| 1 month | 14.63 | | 21.45 |
| Current year | 9.82 | | 21.45 |
| 1 year | 9.82 | | 21.45 |
| 3 years | 9.82 | | 41.51 |
| 5 years | 9.82 | | 188.94 |
| 10 years | 5.95 | | 232.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Leonard
CEO | Chief Executive Officer | 46 | 01/12/2025 |
| Director of Finance/CFO | 52 | 01/01/2025 | |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | 17/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Asaf Danziger
BRD | Director/Board Member | 59 | 01/01/2012 |
Bill Doyle
CHM | Chairman | 63 | 01/01/2009 |
Kin Yip Leung
BRD | Director/Board Member | 64 | 05/08/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/06/26 | Free | Director | 268 | 0.0002% | ||
| 30/06/26 | Free | Chief Executive Officer | 1,905 | 0.0016% | ||
| 30/06/26 | Free | General Counsel | 1,299 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.73% | +16.08% | +47.37% | -51.79% | 2.32B | |
| +0.25% | +0.12% | +38.45% | +5.30% | 12.5B | |
| +0.52% | -0.95% | +14.98% | +20.01% | 6.39B | |
| -0.53% | -2.57% | +45.33% | +20.46% | 5.5B | |
| +2.08% | -1.59% | - | - | 4.59B | |
| -3.39% | -1.19% | -29.45% | +18.83% | 4.47B | |
| -2.85% | -4.45% | -23.96% | -24.19% | 4.03B | |
| -0.34% | -4.23% | -12.63% | +204.03% | 1.71B | |
| +0.33% | +0.33% | +56.68% | -2.86% | 1.55B | |
| -3.08% | -11.78% | -26.08% | -54.41% | 1.22B | |
| Average | -1.47% | +0.72% | +12.30% | +15.04% | 4.43B | |
| Weighted average by Cap. | -0.78% | +0.84% | +18.67% | +11.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 725M 637M 592M 543M 1.02B 69.82B 1.04B 7.03B 2.75B 34.33B 2.72B 2.66B 119B | 811M 712M 662M 608M 1.14B 78.1B 1.16B 7.87B 3.07B 38.4B 3.04B 2.98B 133B |
| Net income | -140M -123M -114M -105M -197M -13.5B -200M -1.36B -531M -6.64B -526M -515M -22.94B | -94.61M -83.09M -77.27M -70.91M -133M -9.11B -135M -918M -358M -4.48B -355M -347M -15.49B |
| Net Debt | -195M -171M -159M -146M -275M -18.78B -279M -1.89B -739M -9.23B -732M -716M -31.93B | -317M -279M -259M -238M -447M -30.54B -454M -3.08B -1.2B -15.02B -1.19B -1.17B -51.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | $18.48 | -7.55% | 2,046,464 |
| 23/07/26 | $19.99 | +28.39% | 8,948,689 |
| 22/07/26 | $15.57 | -2.69% | 1,064,781 |
| 21/07/26 | $16.00 | +0.38% | 1,069,311 |
| 20/07/26 | $15.94 | +0.13% | 933,512 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NVCR Stock
Select your edition
All financial news and data tailored to specific country editions
